|
| Aprepitant | Placebo | Δ | 95% CI | P |
| Vomiting |
|
|
|
|
|
| Within 24 Hoursa | 6/35 (17%) | 17/59 (29%) | −0.12 | −0.29 to 0.05 | 0.20 |
| OR Emergence | 0/44 (0%) | 0/67 (0%) | 0.00 | −0.06 to 0.08 | >0.99 |
| PACU | 3/42 (7%) | 7/60 (12%) | −0.05 | −0.17 to 0.09 | 0.52 |
| 24 Hours | 4/42 (10%) | 13/63 (21%) | −0.11 | −0.24 to 0.02 | 0.13 |
| Medication |
|
|
|
|
|
| PACU to 24 Hours | 21/50 (42%) | 42/70 (60%) | −0.18 | −0.36 to 0.00 | 0.05 |
| OR | 44/50 (88%) | 63/70 (90%) | −0.02 | −0.13 to 0.09 | 0.73 |
| PACU | 13/50 (26%) | 24/70 (34%) | −0.08 | −0.25 to 0.08 | 0.33 |
| 24 Hours | 13/50 (26%) | 24/70 (34%) | −0.08 | −0.25 to 0.08 | 0.33 |
| Nausea |
|
|
|
|
|
| OR Emergence | 0/43 (0%) | 0/67 (0%) | 0.00 | −0.06 to 0.08 | >0.99 |
| 24 Hours | 10/42 (24%) | 24/63 (38%) | −0.14 | −0.32 to 0.03 | 0.12 |